1.
|
Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: KA05028-MA, KA05028, NCT00114829
|
|
2.
|
Phase: Phase IV
Type: Diagnostic, Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: COLOGEN, NCT00138060
|
|
3.
|
Phase: Phase IV
Type: Screening
Status: Active
Age: 52 to 75
Sponsor: Other
Protocol IDs: CDC-NCCDPHP-R-01-PH-000018, NCT00134589
|
|
4.
|
Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DM01VEN/4/03, NCT00199277
|
|
5.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GERCOR-TAUROX, SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885
|
|
6.
|
Phase: Phase IV
Type: Diagnostic, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: KA05030-MA, KA05030, NCT00300547
|
|
7.
|
Phase: Phase IV
Type: Natural history/Epidemiology
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: AVF3991n, NCT00388206
|
|
8.
|
Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07.senna.SMH, NCT00460837
|
|
9.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 123omega, VN2005/35, NCT00488904
|
|
10.
|
Phase: Phase IV
Type: Educational/Counseling/Training, Health services research
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RO1U01CA116924, NCT00496678
|
|
11.
|
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: 01-07, NCT00535652
|
|
12.
|
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CHUL-BIO-COLON, RECF0356, INCA-RECF0356, NCT00559676
|
|
13.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML21380, NCT00577031
|
|
14.
|
Phase: Phase IV
Type: Health services research
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: U01-CA-116892-03, U01-CA-116892-03, NCT00613275
|
|
15.
|
Phase: Phase IV
Type: Diagnostic
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 004907, NCT00626054
|
|
16.
|
Phase: Phase IV
Type: Diagnostic, Screening
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: FHHS, NCT00750763
|
|
17.
|
Phase: Phase IV
Type: Diagnostic, Health services research
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91789, 312041, NCT00764621
|
|
18.
|
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 75 and over
Sponsor: Other
Protocol IDs: I07028, N° EudraCT : 2008-001195-7, NCT00812864
|
|
19.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 74
Sponsor: Other
Protocol IDs: 2009-03, NCT00868569
|
|
20.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2009-04, NCT00874406
|
|
21.
|
Phase: Phase III, Phase II
Type: Diagnostic
Status: Active
Age: 15 and over
Sponsor: Other
Protocol IDs: SP-11-0035, NCT00123760
|
|
22.
|
Phase: Phase III, Phase II
Type: Educational/Counseling/Training, Screening
Status: Approved-not yet active
Age: 50 and over
Sponsor: Other
Protocol IDs: CDC-NCCDPHP-4547, PRC SIP 20-04, NCT00137592
|
|
23.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMT/P2CA/001, LC003AURON2005, NCT00332280
|
|
24.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMT/P2GI/001 Part III, LC001Auron2005, NCT00405561
|
|
25.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001C2241, NCT00419159
|
